FINHUB Insights

IEX · Q2 FY26 · Apr 1 – Jun 30, 2026

IDEX Q2 FY26: where the revenue came from and where it went

IDEX Q2 FY26: revenue $0.9B (+6% year over year). Net profit $0.1B. Largest cohort Health and Science Technologies $0.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Jul 29, 2026 10-Q
Sankey diagram of IDEX's income statement for Q2 FY26: revenue of $0.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.9B +6% year over year
Gross profit$0.4B 46% margin
Operating profit$0.2B 22% margin
Net profit$0.1B 16% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 0.9 100% +6%
Health and Science Technologies 0.4 44% +14%
Fluid and Metering Technologies 0.3 33% +2%
Fire and Safety Diversified… 0.2 22% −1%
Cost of revenue−0.556%
Gross profit0.446% margin+1pp
SG&A−0.224%+1pp
Operating profit0.222% margin+0pp
Net profit0.116%+0pp
Filing on EDGAR More quarters of IEX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters